KOO - valid point.  Still, the company decided to pursue a Nasdaq listing not knowing what the trial results would be if they had announced in the 1Q 2019 as planned. A poor result would have made that tough if the expected timeline for a Nasdaq listing was sometime after that announcement, and I think most people thought that timeline was sometime this spring.  Maybe this is all just another indication as to how confident management is in the trial result?